A randomized controlled trial of the effect of pertussis vaccines on atopic disease

Archives of Pediatrics and Adolescent Medicine

Volumn 152, Issue 8, 1998, Pages 734-738

  Nilsson, Lennart ^a   Kjellman, N I Max ^a   Björkstén, Bengt ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; DIPHTHERIA TETANUS TOXOID; PERTUSSIS VACCINE; TOBACCO SMOKE;

ALLERGY; ARTICLE; ASTHMA; ATOPY; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FAMILY HISTORY; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; PERTUSSIS; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SENSITIZATION; SKIN NODULE; SKIN TEST;

EID: 0031856430     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.152.8.734     Document Type: Article

References (29)

1. Holt PG. Environmental factors and primary T-cell sensitisation to inhalant allergens in infancy: reappraisal of the role of infections and air pollution. Pediatr Allergy Immunol. 1995;6:1-10.
2. Ruffilli A, Bonini S. Susceptibility genes for allergy and asthma. Allergy. 1997;52:256-273.
3. Halken S, Høst A, Nilsson L, Taudorf E. Passive smoking as a risk factor for development of obstructive respiratory disease and allergic sensitization. Allergy. 1995;50:97-105.
4. Redhead K, Watkins J, Barnard A, Mills KHG. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun. 1993;61:3190-3198.
5. Munoz JJ, Peacock MG. Action of pertussigen (pertussis toxin) on serum IgE and Fcε receptors on lymphocytes. Cell Immunol. 1990;127:327-336.
6. Mu HH, Sewell WA. Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunised mice given pertussis toxin. Immunology. 1994;83:639-645.
7. Pauwels R, Van der Straeten M, Platteau B, Bazin H. The non-specific enhancement of allergy: in vivo effects of Bordetella pertussis vaccine on IgE synthesis. Allergy. 1983;38:239-246.
8. Hedenskog S, Björkstén B, Blennow M, Granström G, Granström M. Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and an acellular pertussis vaccine. Int Arch Allergy Appl Immunol. 1989;89:156-161.
9. Schuster A, Hofmann A, Reinhardt D. Does pertussis infection induce manifestation of allergy? Clin Invest. 1993;71:208-213.
10. Wjst M, Dold S, Reitmeir P, Fritzsch C, von Mutius E, Thiemann HH. Pertussis infection and allergic sensitization. Ann Allergy. 1994;73:450-454.
11. Odent MR, Culpin EE, Kimel T. Pertussis vaccination and asthma: is there a link? JAMA. 1994;272:591-592.
12. Odelram H, Granström M, Hedenskog S, Duchen K, Björkstén B. Immunoglobulin E and G responses to pertussis toxin after booster immunization in relation to atopy, local reactions and aluminum content of the vaccines. Pediatr Allergy Immunol. 1994;5:118-123.
13. Nilsson L, Kjellman N-IM, Storsaeter J, Gustafsson L, Olin P. Lack of association between pertussis vaccination and symptoms of asthma and allergy [letter]. JAMA. 1996;275:760.
14. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med. 1996;334:349-355.
15. Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Resp J. 1995;8:483-491.
16. Dreborg S, Frew A. Allergen standardization and skin tests. Allergy. 1993;48 (Suppl 14):49-82.
17. WHO Meeting on Case Definition of Pertussis, Geneva, 10-11 January 1991. Geneva, Switzerland: World Health Organization; 1991:4-5.
18. Altman DG. Practical Statistics for Medical Research. London, England: Chapman & Hall; 1991.
19. Ryan M, Murphy G, Ryan E, Nilsson L, Shackley F, Gothefors L, et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology. 1998;93:1-10.
20. Parfentjev IA, Goodline MA. Histamine shock in mice sensitized with Hemophilus pertussis vaccine. J Pharm Exp Pathol. 1948;92:411-413.
21. Kind LS. The altered reactivity of mice after inoculation with Bordetella pertussis vaccine. Bacteriol Rev. 1958;22:173-182.
22. Malkiel S, Hargis BJ. Sensitization of the mouse to bradykinin. Proc Soc Exp Biol Med. 1967;125:565-567.
23. Munoz J, Schuchardt LF. Effect of H pertussis on sensitivity of mice to cold stress. Proc Soc Exp Biol Med. 1957;94:186-190.
24. Friedman E, Farfel Z, Hanski E. The invasive adenylate cyclase of Bordetella pertussis: properties and penetration kinetics. Biochem J. 1987;243:145-151.
25. Fedyk ER, Adawi A, Looney RJ, Phipps RP. Regulation of IgE and cytokine production by cAMP: implications for extrinsic asthma. Clin Immunol Immunopathol. 1996;81:101-113.
26. Ryan M, Murphy G, Gothefors L, Nilsson L, Storsaeter J, Mills KHG. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 Th cells. J Infect Dis. 1997;175:1246-1250.
27. Hattevig G, Kjellman B, Björkstén B. Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children. Pediatr Allergy Immunol. 1993;4:182-186.
28. Szentivanyi A. The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy. 1968;42:203-232.
29. Ellis EF. Acute bronchopulmonary infections. In: Bierman CW, Pearlman DS. Allergic Diseases From Infancy to Adulthood. Philadelphia, Pa: WB Saunders Co; 1988:537.